News and Resources2024-07-11T15:56:23-05:00

News & Resources

IN THE NEWS

OUR PUBLICATIONS

Predictive modeling of COVID-19 case growth highlights evolving racial and ethnic risk factors in Tennessee and Georgia

The SARS-CoV-2 (COVID-19) pandemic has exposed the need to understand the risk drivers that contribute to uneven morbidity and mortality in US communities. Addressing the community-specific social determinants of health (SDOH) that correlate with spread of SARS-CoV-2 provides an opportunity for targeted public health intervention to promote greater resilience to viral respiratory infections.

CLIENT SUCCESS STORY: Blue Health Intelligence® (BHI®)

Rich claims data from Blue Health Intelligence® (BHI®) made it possible for Decode Health to create comprehensive models that detect patients with undiagnosed or misdiagnosed disease and predict individuals who will likely experience the highest healthcare spend.

Illuminating an Invisible Epidemic: A Systematic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes

A long sought-after goal across a wide range of healthcare specialties is to devise strategies that enhance patient care and simultaneously reduce expenses. Inflammatory diseases and chronic syndromes currently impose an immense social and economic burden on society in terms of both direct and indirect healthcare costs. While published annual [read more...]

WEBINARS

Garbage In, Garbage Out: The Importance of End-to-End Quality Control Processes for RNA Biomarker Discovery

Garbage In, Garbage Out: The Importance of End-to-End Quality Control Processes for RNA Biomarker Discovery

Next-generation RNA sequencing unlocks the discovery of novel candidate biomarkers for diagnostic and therapeutic applications, but reproducibility is a key challenge in biomarker discovery programs. Integrating multi-faceted quality control (QC) steps can improve design decisions and enhance the confidence and reliability of results. This webinar will demonstrate how a comprehensive QC framework supports a disease-agnostic biomarker discovery program to identify biologically relevant candidate biomarkers of complex disease and how this framework can be adapted for total RNA sequencing of whole blood, plasma, and serum samples.

Follow Us

As Seen In

Nashville Post - IQuity News
CNBC logo
Becker's health IT logo

CORPORATE OFFICE

111 10th Avenue South, Suite 102
Nashville, TN 37203

CONTACT US

  855-899-9551
 info@decodehealth.ai

© DECODE HEALTH. ALL RIGHTS RESERVED | PRIVACY POLICY |  FCOI Policy

This website uses cookies and third party services. Click here to read our privacy policy. Ok
Go to Top